Becker's Healthcare January 24, 2025
AbbVie has entered a collaboration with Neomorph to develop molecular glue degraders for oncology and immunology.
Molecular glue degraders are a class of small molecules designed to selectively degrade proteins that contribute to disease, including those involved in cancer growth and immune system dysfunction, according to a Jan. 23 news release from the drugmaker.
...